in this issue
Regions :: Australia/New Zealand
Australia, U.K. Authorities Okay Ranbaxy’s Indian Plant
9:47 AM MDT | April 3, 2009 | Deepti Ramesh
Ranbaxy Laboratories (Gurgaon, India) says that the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) and Australia’s drug regulatory body Therapeutic Goods Administration (Canberra) have issued GMP certificates for Ranbaxy’s Paonta Sahib, India facility, following a joint audit conducted last October. MHRA’s approval will cover U.K. product filings and also apply to product filings for the entire European Union, Ranbaxy says. The U.S. FDA said last month that the Paonta Sahib facility falsified data and test...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee